Can randomised trials rely on existing electronic data? A feasibility study to explore the value of routine data in health technology assessment
Williams J G, Cheung W Y, Cohen D R, Hutchings H A, Longo M F, Russell I T
Record ID 32003001082
English
Authors' objectives:
The objectives were to estimate the feasibility, utility and resource implications of electronically captured routine data for health technology assessment by RCTs, and to recommend how routinely collected data could be made more effective for this purpose.
Authors' results and conclusions:
The study has shown that some of the research questions posed by health technology assessment through RCTs can indeed be answered using routinely collected data. Where these questions require analysis of NHS resource use, data can usually be identified. Clinical effectiveness can also be judged, using proxy measures for quality of life (QoL), provided clinical symptoms and signs are collected in sufficient detail. Patient and professional preferences cannot be identified from routine data but could be collected routinely by adapting existing instruments.
Routine data are potentially cheaper to extract and analyse than designed data. In addition, they facilitate recruitment. They also have the potential to identify patient outcomes captured in remote systems that may be missed in designed data collection.
Notwithstanding these potential benefits, the study confirmed previous evidence that the validity of routinely collected data is suspect, particularly in systems that are not under clinical and professional control. There are also potential difficulties in identifying, accessing and extracting data, and in the lack of uniformity in data structures, coding systems and definitions. While data validity remains suspect there is likely to be resistance among researchers to the use of routine data for health technology assessment by RCTs.
Authors' recommendations:
Routine data have the potential to support health technology assessment by RCTs. The cost of data collection and analysis is likely to fall, although further work is required to improve the validity of routine data, particularly in central returns. Better knowledge of the capability of local systems and access to the data held on them is also essential. Routinely captured clinical data have real potential to measure patient outcomes, if the data were collected in detail and with precision.
Authors' methods:
Randomised controlled trial
Details
Project Status:
Completed
URL for project:
http://www.hta.ac.uk/957
Year Published:
2003
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Data Collection
- Technology Assessment, Biomedical
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2009 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.